Ensign Peak Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$431K Hold
2025
Q1
$357K Hold
2024
Q4
$495K Sell
2024
Q3
$2.13M Sell
2024
Q2
$2.34M Hold
2024
Q1
$2.67M Sell
2023
Q4
$3.24M Buy
2023
Q3
$547K Buy
2023
Q2
Sell
2023
Q1
$248K Buy